SCHEMBL1364923

SCHEMBL1364923

Cc1nc(-c2ccccc2)ncc1C(=O)NC1CCN(C)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DGAT1 O75907 1/20 0.53
▸ KMT2A Q03164 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ ATR Q13535 2/20 0.49
▸ GABRA5 P31644 1/20 0.48
▸ CKS1B P61024 2/20 0.47
▸ SKP1 P63208 2/20 0.47
▸ SKP2 Q13309 2/20 0.47
▸ DYRK1A Q13627 1/20 0.47
▸ POLR1A O95602 1/20 0.46
▸ CHEK2 O96017 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ CSNK1D P48730 2/20 0.45
▸ AXL P30530 2/20 0.45
▸ DCLK1 O15075 1/20 0.45
▸ PDPK1 O15530 1/20 0.45
▸ PRKD3 O94806 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14094525 0.91 DGAT1 (0.53) DGAT1KMT2AKDM4EALDH1A1HPGD
SCHEMBL12141992 0.89 KMT2A (0.51) KMT2AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL1367559 0.88 DGAT1 (0.51) DGAT1ALDH1A1GABRA5CKS1BSKP1
SCHEMBL12141988 0.88 ATR (0.55) KMT2AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL1366388 0.86 POLB (0.63) KMT2AMAPK1PRKAA1JAK3
SCHEMBL4406616 0.85 KDM4E (0.58) KMT2AKDM4EALDH1A1HPGDHSD17B10
SCHEMBL1364239 0.84 DGAT1 (0.48) DGAT1KMT2AKDM4EALDH1A1HPGD
SCHEMBL4636340 0.83 GABRA5 (0.55) KMT2AATRGABRA5CKS1BSKP1
SCHEMBL1366822 0.83 DRD4 (0.60) DGAT1KDM4EALDH1A1MAPK1PRKAA1
SCHEMBL1366703 0.82 DGAT1 (0.55) DGAT1GABRA5AXLFLT3TYRO3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8067589-B2 Heterocyclic compounds useful in treating diseases and conditions PFIZER INC (US) 2011-11-29 — — US disclosed
US-8067589-B2 Heterocyclic compounds useful in treating diseases and conditions PFIZER INC (US) 2011-11-29 — — US disclosed
US-20090281125-A1 Heterocyclic Compounds Useful in Treating Diseases and Conditions BLAKE TANISHA D 2009-11-12 — — US disclosed
US-20090281125-A1 Heterocyclic Compounds Useful in Treating Diseases and Conditions BLAKE TANISHA D 2009-11-12 — — US disclosed
US-7582643-B2 Heterocyclic compounds useful in treating diseases and conditions PFIZER INC (US) 2009-09-01 — — US disclosed
US-7582643-B2 Heterocyclic compounds useful in treating diseases and conditions PFIZER INC (US) 2009-09-01 — — US disclosed
US-20080207651-A1 Heterocyclic compounds useful in treating diseases and conditions BLAKE TANISHA D 2008-08-28 — — US disclosed
US-20080207651-A1 Heterocyclic compounds useful in treating diseases and conditions BLAKE TANISHA D 2008-08-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281125-A1 Heterocyclic Compounds Useful in Treating Diseases and Conditions CYP11B2, CYP11B1, LTC4S DGAT1 1566/4885KMT2A 2693/4885KDM4E 3037/4885
US-20080207651-A1 Heterocyclic compounds useful in treating diseases and conditions CYP11B2, CYP11B1, LTC4S DGAT1 1566/4885KMT2A 2693/4885KDM4E 3037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback